Search
Selected: U

Use of a promoter of T-cell expansion and an inducer of CD40...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of a promoter of T-cell expansion and an inducer of CD40...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of a promoter of T-cell expansion and an inducer of CD40...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of an interleukin-10 antagonist to treat a B cell mediated a

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of arginine as an lymphokine synergist

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of cytokines and mitogens to inhibit pathological immune...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of gp130 activators in diabetic neuropathy

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-10 to stimulate peripheral blood mononuclear cell cyto

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-10 to treat inflammatory bowel disease

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-12 and IFN.alpha. for the treatment of infectious dise

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-13 to induce 15-lipoxygenase

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-22 for the treatment of conditions of metabolic...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-4 for inhibition of the breakdown of articular cartila

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-4 for potentiation of chemotherapeutic agents

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-4 to treat solid tumors

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-6 for the treatment of chronic lymphocyte leukemia (CL

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-6 to treat toxic shock

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of IL-7 for treating auto-immune diseases and...

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of interleukin 7 to enhance humoral immunity

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of interleukin-1 (IL-1) to inhibit development of hepatitis

Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.